
India is poised to become a global leader in homoeopathy, supported by a large network of over 250,000 registered practitioners, nearly 300 teaching institutions, and millions of patients. Experts highlight two key quality frameworks—the AYUSH Premium Mark and NABL accreditation—that ensure international standards in manufacturing and testing. These certifications, combined with India's clinical expertise and data, position Indian homoeopathy to challenge the longstanding dominance of German brands in the global market valued at USD 8 to 10 billion.
Select a news story to see related coverage from other media outlets.